Special Edition: COVID-19 ResourcesMarch 30, 2020 | Oncology Allergy & Immunology Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-label Non-randomized Clinical Trial Despite a small sample size, a recent trial demonstrated hydroxychloroquine treatment’s effect reinforced by azithromycin is significantly associated with viral load reduction/disappearance in COVID-19 patients. Read full article Geriatrics Hospital in Wuhan, China Says Patients with Cancer are More Susceptible to COVID-19 According to JAMA Oncology, researchers located in Wuhan, China – the epicenter of the COVID-19 outbreak – there were more coronavirus cases among patients with cancer versus the general public. Read full article
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS